Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study
Resource Type
Article
Authors
Jones, Stephen E ; Collea, Rufus ; Paul, Devchand ; Sedlacek, Scot ; Favret, Anne M ; Gore, Ira, Jr ; Lindquist, Deborah L ; Holmes, Frankie Ann ; Allison, Mary Ann K ; Brooks, Barry D ; Portillo, Raul M ; Vukelja, Svetislava J ; Steinberg, Michael S ; Stokoe, Christopher ; Crockett, Maria W ; Wang, Yunfei ; Asmar, Lina ; Robert, Nicholas J ; O'Shaughnessy, Joyce
Source
In The Lancet Oncology October 2013 14(11):1121-1128
Subject
Primary Research Articles
Language
ISSN
1470-2045